Results 11 to 20 of about 169,757 (284)
Chronic myelogenous leukemia in Libya
South Asian Journal of Cancer, 2012 Itrat Mehdi, Arshad Hussain Kashmiri
doaj +4 more sources
Chronic Myelogenous Leukemia [PDF]
Hematology, 2002 Abstract The treatment options for chronic myelogenous leukemia (CML) continue to evolve rapidly. Imatinib mesylate (Gleevec, Glivec, formerly STI571) has continued to show remarkable clinical benefits and the updated results with this agent are reviewed.
Jorge E. Cortes +3 more
openaire +5 more sources
Granulocytic Sarcoma with Compressive Myelopathy: A Rare Presentation of Chronic Myelogenous Leukemia [PDF]
Journal of Clinical and Diagnostic Research, 2014 Granulocytic sarcoma occurs most commonly in acute myelogenous leukemia. The appearance of granulocytic sarcoma in chronic myelogenous leukemia signals accelerated phase/ blast transformation.
Abhijeet P. Ganapule +4 more
doaj +1 more source
Chronic Myelogenous Leukemia [PDF]
Journal of the National Comprehensive Cancer Network, 2012 Chronic myelogenous leukemia (CML) is the one of the most common chronic myeloproliferative disorders. It has become the paradigmatic disease for molecular diagnosis and monitoring for several reasons: (1) CML has a unitary molecular definition, requiring the demonstration of the t(9;22)(q34;q11) chromosomal translocation or its product, the BCR-ABL ...
Susan, O'Brien +19 more
openaire +5 more sources
Acute appendicitis revealing a diagnosis of chronic myelogenous leukemia
Clinical Case Reports, 2021 Gastrointestinal manifestations of leukemias have been well recognized. Typically, acute leukemias cause typhlitis or appendicitis more commonly than chronic leukemias.
Rita Ahmad +6 more
doaj +1 more source
Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission
Онкогематология, 2015 The article presents example of modeling for pharmacoeconomical-founded choice of chronic myelogenous leukemia treatment strategy related to therapeutic efficacy and economical rationality. The economic model of chronic myelogenous leukemia diagnosis and
V. A. Shuvaev +3 more
doaj +3 more sources
A study on the cytomorphologic structure of blood cells by vital staining II. Leukemic cells in the bone marrow [PDF]
, 1960 Leukemic cells were cytologically studied in the human bone marrow culture by the utilization of vital staining of Janus green B and neutral red. The minute cellular morphology of various types of leukemia was studied with special reference to their ...
Ota, Zensuke
core +1 more source
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.
Blood, 1975 A cell-line derived from a patient with chronic myelogenous leukemia (CML) is described. The new cell-line, which has over 175 serial passanges in a 3 1/2-yr period, has the following characteristics: (1) CML cells started to proliferate actively since ...
C. Lozzio, B. Lozzio
semanticscholar +1 more source
The chronic myeloid leukemia stem cell: stemming the tide of persistence [PDF]
, 2017 Chronic myeloid leukaemia (CML) is caused by the acquisition of the tyrosine kinase BCR-ABL1 in a haemopoietic stem cell (HSC), transforming it into a leukaemic stem cell (LSC) that self-renews, proliferates and differentiates to give rise to a ...
Holyoake, Tessa L., Vetrie, David
core +1 more source
Dasatinib: ten years of clinical practice worldwide
Онкогематология, 2016 The article contains results of meta-analysis of experience in use of second-generation tyrosine kinase inhibitors – dasatinib. The results of clinical trials dasatinib therapy in chronic myelogenous leukemia imatinib-resistant or intolerant patients are
K. M. Abdulkadyrov +2 more
doaj +1 more source